company background image
RJF logo

Laboratorio Reig Jofre BME:RJF Stock Report

Last Price

€2.86

Market Cap

€225.4m

7D

-10.6%

1Y

10.0%

Updated

23 Jun, 2024

Data

Company Financials +

Laboratorio Reig Jofre, S.A.

BME:RJF Stock Report

Market Cap: €225.4m

RJF Stock Overview

A pharmaceutical company, engages in the research, development, manufacture, and marketing of pharmaceutical products and specialties, as well as accessories authorized foodstuffs, dietary and personal care products, and cosmetics.

RJF fundamental analysis
Snowflake Score
Valuation2/6
Future Growth4/6
Past Performance2/6
Financial Health5/6
Dividends2/6

Laboratorio Reig Jofre, S.A. Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Laboratorio Reig Jofre
Historical stock prices
Current Share Price€2.86
52 Week High€3.38
52 Week Low€2.15
Beta0.89
11 Month Change2.88%
3 Month Change14.86%
1 Year Change10.00%
33 Year Change-42.11%
5 Year Change23.28%
Change since IPO-25.13%

Recent News & Updates

Calculating The Fair Value Of Laboratorio Reig Jofre, S.A. (BME:RJF)

Jun 22
Calculating The Fair Value Of Laboratorio Reig Jofre, S.A. (BME:RJF)

Recent updates

Calculating The Fair Value Of Laboratorio Reig Jofre, S.A. (BME:RJF)

Jun 22
Calculating The Fair Value Of Laboratorio Reig Jofre, S.A. (BME:RJF)

These 4 Measures Indicate That Laboratorio Reig Jofre (BME:RJF) Is Using Debt Extensively

Feb 02
These 4 Measures Indicate That Laboratorio Reig Jofre (BME:RJF) Is Using Debt Extensively

This Analyst Just Downgraded Their Laboratorio Reig Jofre, S.A. (BME:RJF) EPS Forecasts

Mar 07
This Analyst Just Downgraded Their Laboratorio Reig Jofre, S.A. (BME:RJF) EPS Forecasts

We Think Laboratorio Reig Jofre (BME:RJF) Is Taking Some Risk With Its Debt

Mar 07
We Think Laboratorio Reig Jofre (BME:RJF) Is Taking Some Risk With Its Debt

Laboratorio Reig Jofre (BME:RJF) Seems To Use Debt Quite Sensibly

May 17
Laboratorio Reig Jofre (BME:RJF) Seems To Use Debt Quite Sensibly

The Laboratorio Reig Jofre (BME:RJF) Share Price Has Gained 146%, So Why Not Pay It Some Attention?

Mar 07
The Laboratorio Reig Jofre (BME:RJF) Share Price Has Gained 146%, So Why Not Pay It Some Attention?

Is Laboratorio Reig Jofre (BME:RJF) Using Too Much Debt?

Jan 14
Is Laboratorio Reig Jofre (BME:RJF) Using Too Much Debt?

Laboratorio Reig Jofre (BME:RJF) Shareholders Booked A 47% Gain In The Last Year

Dec 05
Laboratorio Reig Jofre (BME:RJF) Shareholders Booked A 47% Gain In The Last Year

Shareholder Returns

RJFES PharmaceuticalsES Market
7D-10.6%-0.1%0.3%
1Y10.0%19.9%16.7%

Return vs Industry: RJF underperformed the Spanish Pharmaceuticals industry which returned 19.9% over the past year.

Return vs Market: RJF underperformed the Spanish Market which returned 16.7% over the past year.

Price Volatility

Is RJF's price volatile compared to industry and market?
RJF volatility
RJF Average Weekly Movement6.3%
Pharmaceuticals Industry Average Movement5.0%
Market Average Movement3.1%
10% most volatile stocks in ES Market6.3%
10% least volatile stocks in ES Market0.9%

Stable Share Price: RJF has not had significant price volatility in the past 3 months.

Volatility Over Time: RJF's weekly volatility (6%) has been stable over the past year, but is still higher than 75% of Spanish stocks.

About the Company

FoundedEmployeesCEOWebsite
19291,331Ignasi Reigwww.reigjofre.com

Laboratorio Reig Jofre, S.A., a pharmaceutical company, engages in the research, development, manufacture, and marketing of pharmaceutical products and specialties, as well as accessories authorized foodstuffs, dietary and personal care products, and cosmetics. The company offers nutritional and parapharmacy products. Its products also include pharmaceutical technologies products, such as antibiotics, and injectables and other products; specialty pharmacare products, which include skin, hair, nails, joint health and pain, and women’s health; and food supplements under the Forté Pharma brand.

Laboratorio Reig Jofre, S.A. Fundamentals Summary

How do Laboratorio Reig Jofre's earnings and revenue compare to its market cap?
RJF fundamental statistics
Market cap€225.37m
Earnings (TTM)€8.85m
Revenue (TTM)€325.74m

25.5x

P/E Ratio

0.7x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
RJF income statement (TTM)
Revenue€325.74m
Cost of Revenue€145.12m
Gross Profit€180.63m
Other Expenses€171.78m
Earnings€8.85m

Last Reported Earnings

Mar 31, 2024

Next Earnings Date

Jul 30, 2024

Earnings per share (EPS)0.11
Gross Margin55.45%
Net Profit Margin2.72%
Debt/Equity Ratio21.8%

How did RJF perform over the long term?

See historical performance and comparison

Dividends

1.4%

Current Dividend Yield

34%

Payout Ratio
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.